" class="no-js "lang="en-US"> Clinical Trials Archives - Medtech Alert
Wednesday, June 12, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

SciTech Development Raises $2.73 Million in Oversubscribed Funding Round to Advance Clinical Trials for Cancer Treatment

SciTech Development has announced it has closed a $2.73M funding round, led by several prominent […]

TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion as mRNA Manufacturing Facility Nears Completion

TriLink BioTechnologies, a Maravai LifeSciences company and global provider of life science reagents and services, […]

RQM+ Acquires Libra Medical

RQM+, the world’s leading MedTech service provider, has announced the acquisition of Libra Medical, a […]

FDA Issues Draft Guidance Aimed at Improving Oncology Clinical Trials for Accelerated Approval

The United States Food and Drug Administration (FDA) issued draft guidance, Clinical Trial Considerations to […]

ObvioHealth Announces Ground-Breaking Digital Therapeutics API to Capture More Accurate Efficacy and Adherence Data in Clinical Trials

ObvioHealth, a pioneering virtual research organization, announces the launch of a proprietary application programming interface […]

Vysioneer Announces Data Sharing Agreement with Pfizer to Augment Oncology Clinical Trials with Artificial Intelligence

Vysioneer, a pioneer in AI for Oncology, today announced a data-sharing agreement with Pfizer, a […]

OxSonics Announces First-in-human Clinical Data Shows SonoTran(R) is Safe and Well-tolerated

OxSonics Therapeutics, a clinical-stage medtech company focused on transforming cancer treatment through SonoTran, its proprietary […]

Huma to Provide Best-in-class Digital Clinical Trials Solutions Through Landmark Acquisition of Alcedis

Huma Therapeutics, a leading global digital health company, today announced that it has acquired Alcedis […]

Sustained Therapeutics Advancing Clinical Trial for Novel Drug Delivery Platform

A Vancouver-based therapeutics company, Sustained Therapeutics, has received regulatory approval to begin the second Phase […]

OnQuality Pharmaceuticals Expands Part 2 of the NOVA-II Phase 2 Clinical Trial to China and India

OnQuality Pharmaceuticals, a targeted oncology supportive therapy company developing innovative medications to address the quality […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more